Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBCS and 5-FU in Endoscopic Dacryocystorhinostomy
NCT06175676Phase 1Completed
- Sponsor
- Tianjin Medical University Eye Hospital
- Start
- Dec 2021
- Primary completion
- Jun 2023
- Modality
- Polymer-based Nanoparticles, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of hydroxybutyl chitosan and fluorouracil in dacryocystitis (3 arms), sponsored by Tianjin Medical University Eye Hospital. Primary endpoint: Clinical symptoms at 6 months. Started Dec 2021; status: completed.
02
Drugs
hydroxybutyl chitosanfluorouracil
03
Conditions
dacryocystitis
Beyond the preview
Go deeper on NCT06175676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06175676.